AD_728x90

New Study: Esketamine Helps Prevent Postpartum Depression

Bookmark Article

Share

Share

Bookmark Article

KEY POINTS

On ‘Psychology Behind the Headlines,’ hosts Jessica Reyes, Patricia Wu, and guest therapist Ryan Heapy discuss about the new drug that can reduce the risk of severe depression in new mothers.

What is esketamine? 

A nasal spray related to ketamine, with antidepressant properties.

Study shows potential

Women who received esketamine were less likely to need serious depression care after childbirth.

Global impact

The study highlights a shift towards innovative mental health treatment options.

Editorial Team
Editorial Teamhttps://mhtn.org/
At the heart of MHTN - America's pioneering 24/7 Mental Health TV Network - is our editorial team, a dynamic group of professionals united by a shared commitment to transforming the conversation around mental health. Our team is composed of seasoned journalists, mental health experts, researchers, and storytellers, each bringing a wealth of experience and a passion for advocacy.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Read more

Advertisement

Related Articles

[yarpp]